Lyka Labs Limited has informed the Exchange about General Updates
LYKALABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.8 pts less than Nifty Microcap 250 and 1.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Lyka Labs Limited informed the exchanges about an update on its ongoing Scheme of Amalgamation with Lyka Exports Limited (Transferor Company). The National Company Law Tribunal (NCLT), Ahmedabad, heard the matter and the company's counsel submitted the compliance affidavit regarding Import Export Code and FEMA guidelines. The NCLT has reserved its order, meaning the ruling will be pronounced on a later date. The company previously informed the exchanges about this matter on 2nd February 2026. The order copy is also available on Lyka Labs' website.
This is a procedural update in the ongoing amalgamation process. Shareholders should watch for the NCLT's reserved order, as its outcome will determine whether the amalgamation between Lyka Exports and Lyka Labs receives approval and can move forward. No immediate material impact on stock price, but the final NCLT decision will be a key catalyst.